| Option Care | |
| 7325 W Deschutes Ave, Ste C, Kennewick, Washington 99336 | |
| (509) 783-2273 |
| Name | Option Care |
|---|---|
| Organization Name | Option Care Enterprises Inc |
| Location | 7325 W Deschutes Ave, Ste C, Kennewick, Washington 99336 |
| Type | Supplier |
| Phone | (509) 783-2273 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
One year ago, the 192 Member States of the World Health Organization unanimously adopted the Framework Convention on Tobacco Control, the first public health treaty ever negotiated under the auspices of WHO. Since then, 118 Member States have signed the FCTC, including China in November 2003.
New research indicates that psychiatric illnesses are common in children and adults with kidney failure, and hospitalizations for such illnesses are associated with a higher risk of early death in adults.
For cancer to spread, the cells that take off into the bloodstream must find a tissue that will permit them to thrive. They don't just go looking, though. Instead, they actively prepare the tissue, in one case by co-opting a protein that suppresses defenses the body would otherwise mount.
Octapharma, one of the largest human protein products manufacturers in the world, today announced that patients diagnosed with severe hemophilia A have started treatment with the first recombinant Factor VIII derived from a human cell line (Human-cl rhFVIII). Researchers are investigating pharmacokinetics, efficacy, safety and immunogenicity of Human-cl rhFVIII for previously treated patients with severe hemophilia A.
Axelar AB today announces that the first submitted medical article on the ongoing phase I/II cancer study with AXL1717 has been published in Acta Oncologica.
› Verified 4 days ago
News Archive
One year ago, the 192 Member States of the World Health Organization unanimously adopted the Framework Convention on Tobacco Control, the first public health treaty ever negotiated under the auspices of WHO. Since then, 118 Member States have signed the FCTC, including China in November 2003.
New research indicates that psychiatric illnesses are common in children and adults with kidney failure, and hospitalizations for such illnesses are associated with a higher risk of early death in adults.
For cancer to spread, the cells that take off into the bloodstream must find a tissue that will permit them to thrive. They don't just go looking, though. Instead, they actively prepare the tissue, in one case by co-opting a protein that suppresses defenses the body would otherwise mount.
Octapharma, one of the largest human protein products manufacturers in the world, today announced that patients diagnosed with severe hemophilia A have started treatment with the first recombinant Factor VIII derived from a human cell line (Human-cl rhFVIII). Researchers are investigating pharmacokinetics, efficacy, safety and immunogenicity of Human-cl rhFVIII for previously treated patients with severe hemophilia A.
Axelar AB today announces that the first submitted medical article on the ongoing phase I/II cancer study with AXL1717 has been published in Acta Oncologica.
› Verified 4 days ago
Clearwater Family Eye Care Type: Medicare Supplier Location: 6515 W Clearwater Ave, Kennewick, Washington 99336 Phone: (509) 737-2020 | |
Sav-on Pharmacy #3253 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5204 W Clearwater Ave, Kennewick, Washington 99336 Phone: (509) 735-8311 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6503w Hood Pl A, Kennewick, Washington 99336 Phone: (509) 783-8413 | |
Center Vision & Contact Lens Clinic Type: Medicare Supplier Location: 8127 W Grandridge Blvd, Kennewick, Washington 99336 Phone: (509) 783-8383 | |
Columbia Basin Prosthetics & Orthot Type: Prosthetic/Orthotic Supplier Location: 2624 W Deschutes Ave, Kennewick, Washington 99336 Phone: (509) 737-8322 |